Trump Announces Deals to Lower Weight Loss Drug Prices to $150/Month

New Deals for Weight Loss Drugs

• 🎯 Eli Lilly and Novo Nordisk have agreed to offer their popular GLP1 weight loss drugs at drastic discounts.
• 💡 The administration announced these deals aim to make weight loss drugs more accessible and affordable for more Americans.

Reduced Pricing and Accessibility

• 💰 The cost is expected to drop to less than $150 for a month's supply, which is reportedly one-ninth of the current price.
• 🏥 These reduced prices will be available to patients on Medicaid and Medicare, as well as those purchasing directly through Trump RX.

Timeline for Price Reduction

• 🗓️ The new pricing is anticipated to be available early next year.
• 📅 Specifically, Trump RX is expected to launch no later than January, while Medicare coverage could begin by May 2026.
• state-by-state basis for Medicaid.

Broader Health Initiative

• 📈 The administration views these deals as a significant step in the "war against obesity".
• ✅ The goal is to increase the number of Americans who can access and benefit from these weight loss medications.